Ascendis Pharma A/S (ASND)
228.65
+11.99
(+5.53%)
USD |
NASDAQ |
Jan 22, 16:00
228.91
+0.26
(+0.11%)
After-Hours: 07:28
Ascendis Pharma Research and Development Expense (TTM): 326.69M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Novo Nordisk A/S | 7.615B |
| Evaxion AS | 9.769M |
| DBV Technologies SA | 95.77M |
| Cellectis SA | 70.72M |
| Biodexa Pharmaceuticals Plc | 6.352M |